Acute endovascular stroke therapy

American Journal of Therapeutics

Volumn 18, Issue 1, 2011, Pages 57-63

  Chen, Michael ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

angiography; catheter; device; large vessel occlusion; stroke; thrombolysis

Indexed keywords

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); HEART INFARCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MECHANICAL THROMBECTOMY; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; RECANALIZATION; RISK ASSESSMENT; STENT; THROMBECTOMY; THROMBUS ASPIRATION;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; CEREBROVASCULAR CIRCULATION; ENDOVASCULAR PROCEDURES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; PATIENT SELECTION; STROKE; SUCTION; THROMBECTOMY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 78751642832     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181e32e40     Document Type: Article

References (33)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:948-954.
2. Spieler JF, Lanoe JL, Amarenco P. Costs of stroke care according to handicap levels and stroke subtypes. Cerebrovasc Dis. 2004;17:134-142.
3. Jones TH, Morawetz RB, Crowell RM, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg. 1981;54:773-782.
4. Baron JC. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis. 2001;11(Suppl 1):2-8
5. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333: 1581-1587.
6. Liang BA, Zivin JA. Empirical characteristics of litigation involving tissue plasminogen activator and ischemic stroke. Ann Emerg Med. 2008;52:160-164.
7. Reeves MJ, Arora S, Broderick JP, et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke. 2005;36: 1232-1240.
8. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke. 2007;38:948-954.
9. Smith WS, Tsao JW, Billings ME, et al. Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia. Neurocrit Care. 2006;4:14-17.
10. Gonzalez RG. Imaging-guided acute ischemic stroke therapy: from 'time is brain' to 'physiology is brain.' AJNR Am J Neuroradiol. 2006;27:728-735.
11. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PRO ACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282: 2003-2011.
12. Wunderlich MT, Goertler M, Postert T, et al. Recanaliza-tion after intravenous thrombolysis: does a recanalization time window exist? Neurology. 2007;68:1364-1368.
13. Smith WS, Sung G, Saver J, et al. Mechanical thrombec-tomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39:1205-1212.
14. Henkes H, Reinartz J, Lowens S, et al. A device for fast mechanical clot retrieval from intracranial arteries (Phe-nox clot retriever). Neurocrit Care. 2006;5:134-140.
15. Henkes H, Lowens S, Preiss H, et al. A new device for endovascular coil retrieval from intracranial vessels: alligator retrieval device. AJNR Am J Neuroradiol. 2006; 27:327-329.
16. Veznedaroglu E, Levy EI. Endovascular management of acute symptomatic intracranial arterial occlusion. Neuro-surgery. 2006;59(Suppl 3):S242-S250; discussion S253-S313.
17. Bose A, Henkes H, Alfke K, et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol. 2008;29: 1409-1413.
18. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40:2761-2768.
19. Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery. 2002;51:1319-1327; discussion 1327-1329.
20. Kerber CW, Barr JD, Berger RM, et al. Snare retrieval of intracranial thrombus in patients with acute stroke. J Vasc Interv Radiol. 2002;13:1269-1274.
21. Nogueira RG, Schwamm LH, Buonanno FS, et al. Low-pressure balloon angioplasty with adjuvant pharmacological therapy in patients with acute ischemic stroke caused by intracranial arterial occlusions. Neuroradiology. 2008;50:331-340.
22. Levy EI, Siddiqui AH, Crumlish A, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke. 2009;40:3552-3556.
23. Fisher M, Adams RD. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol. 1951;10:92-94.
24. Trouillas P, von Kummer R. Classification and pathogen-esis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke. 2006;37:556-561.
25. Motto C, Ciccone A, Aritzu E, et al. Hemorrhage after an acute ischemic stroke. MAST-I Collaborative Group. Stroke. 1999;30:761-764.
26. Jaillard A, Cornu C, Durieux A, et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke. 1999;30:1326-1332.
27. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29:4-11.
28. Vora NA, Gupta R, Thomas AJ, et al. Factors predicting hemorrhagic complications after multimodal reperfusion therapy for acute ischemic stroke. AJNR Am J Neuroradiol. 2007;28:1391-1394.
29. Singer OC, Kurre W, Humpich MC, et al. Risk assessment of symptomatic intracerebral hemorrhage after thrombol-ysis using DWI-ASPECTS. Stroke. 2009;40:2743-2748.
30. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.
31. Ribo M, Molina CA, Rovira A, et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3-to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke. 2005;36:602-606.
32. Lago A, Geffner D, Tembl J, et al. Circadian variation in acute ischemic stroke: a hospital-based study. Stroke. 1998; 29:1873-1875.
33. Hallevi H, Barreto AD, Liebeskind DS, et al. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke. 2009;40:1780-1785.